19 - 22 Oct 2025 | Las Vegas

Longevity Wonder Drugs

About this Session:

GLP-1 medications started as diabetes drugs, graduated to weight loss superstars, and now they're auditioning for the role of a universal health optimizer—with mounting evidence showing benefits for everything from cardiovascular disease and kidney function to addiction recovery and even migraine prevention. The scope of their therapeutic potential is genuinely exciting. With the ability to rewire how our bodies respond to metabolic stress, longevity researchers are questioning if healthy people should be taking GLP-1s as a preventive measure, the same way we take statins for cholesterol or aspirin for heart health. The emerging research is painting GLP-1s as potential longevity enhancers that could help us live not just longer, but healthier lives by addressing multiple age-related diseases simultaneously through pathways we're only beginning to understand. But are we getting ahead of ourselves when we're still learning about their long-term effects and have not yet addressed adherence challenges? Either way, GLP-1s are reshaping how we think about preventive medicine and the future of healthy aging.